Core Insights - Glucose Health, Inc. has appointed Christopher J. Jemapete to its Board of Directors, effective immediately, strengthening its leadership team [1] - Mr. Jemapete has extensive experience in the financial services sector, having held senior positions at notable firms such as E.F. Hutton, Shearson Lehman Brothers, and Fidelity Investments [2] - Since his retirement in 2010, Mr. Jemapete has focused on investment opportunities in the micro-cap sector, gaining insights into the challenges faced by emerging companies [3] Company Developments - Mr. Jemapete has been an early strategic investor in Glucose Health, participating in all Private Placements since 2019 and helping raise over $2 million in capital [4] - He emphasizes the importance of adequate capitalization for the company to fully implement its strategic business plan and drive revenue growth [5] - The company has established a strong retail distribution network for its products, GLUCODOWN® and FIBER UP®, through major partners including Amazon and leading pharmacy chains in the U.S. [5]
Glucose Health, Inc. Appoints Strategic Investor Christopher J. Jemapete to Its Board of Directors
Globenewswire·2025-10-29 12:00